Novo Nordisk A S (NVO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Novo Nordisk A S.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 23 | $86.86 | $52.6 | $72.51 | $79.1 | -8.33% |
The Trend in the Analyst Price Target
NVO's average price target has moved up $4.49 over the prior 140 days.
NVO reports an average of 5.3% for its upside potential over the past 174 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2020-11-26 | 23 | 86.86 | 52.60 | 72.51 | 66.14 | 9.63% |
| 2020-11-18 | 23 | 86.86 | 52.60 | 72.50 | 66.52 | 8.99% |
| 2020-11-11 | 23 | 86.86 | 52.39 | 72.31 | 67.70 | 6.81% |
| 2020-10-30 | 21 | 86.52 | 51.63 | 72.39 | 63.89 | 13.3% |
| 2020-10-05 | 22 | 83.46 | 52.27 | 71.39 | 70.12 | 1.81% |
| 2020-09-26 | 21 | 83.46 | 52.27 | 71.85 | 69.06 | 4.04% |
| 2020-09-18 | 23 | 83.46 | 52.27 | 72.31 | 69.44 | 4.13% |
| 2020-09-05 | 24 | 83.46 | 46.43 | 70.96 | 65.11 | 8.98% |
| 2020-08-27 | 24 | 83.46 | 46.43 | 70.88 | 66.26 | 6.97% |
| 2020-08-20 | 25 | 83.46 | 46.43 | 70.80 | 66.49 | 6.48% |
| 2020-08-12 | 25 | 83.46 | 46.43 | 70.82 | 67.09 | 5.56% |
| 2020-08-07 | 25 | 83.46 | 46.43 | 70.60 | 64.64 | 9.22% |
| 2020-07-23 | 25 | 82.76 | 46.43 | 68.90 | 66.42 | 3.73% |
| 2020-07-16 | 25 | 82.76 | 46.43 | 68.62 | 65.66 | 4.51% |
| 2020-07-09 | 25 | 82.76 | 45.61 | 68.02 | 65.61 | 3.67% |
| 2020-07-02 | 25 | 82.76 | 45.61 | 67.76 | 66.36 | 2.11% |
| 2020-06-25 | 25 | 82.76 | 45.61 | 67.43 | 67.25 | 0.27% |
| 2020-06-20 | 25 | 82.76 | 45.61 | 67.37 | 67.55 | -0.27% |
| 2020-06-11 | 24 | 79.65 | 45.61 | 66.60 | 64.42 | 3.38% |
| 2020-06-05 | 24 | 79.65 | 45.61 | 66.28 | 64.49 | 2.78% |
NVO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|
The Trend in the Broker Recommendations
Over the past 31 days, NVO's average broker recommendation rating improved by 0.04.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NVO as an investment opportunity.
- Novo Nordisk A S's number of analysts covering the stock is greater than 96.26% of all US stocks.
- The upside potential (average analyst target price relative to current price) of NVO is greater than 3.65% of Pharmaceutical Products stocks.
- The average analyst price target of NVO is greater than 86.72% of Pharmaceutical Products stocks.
- Novo Nordisk A S's variance in analysts' estimates is less than 26.54% of all US stocks.
Is NVO a Buy, Hold or Sell? See the POWR Ratings now!